FECAL MICROBIOTA SIGNATURES ARE ASSOCIATED WITH DISEASE SEVERITY AND LOCATION IN INFLAMMATORY BOWEL DISEASE

Christopher Morehouse  1     Ben Sparklin  2     Antonio DiGiandomenico  2     Vancheswaran Gopalakrishnan  2     Bastian Angermann  3     Ulf Gehrmann  3     Jessica Neisen  4     Emon Khan  4     Junmei Cairns  4    
1 AstraZeneca, Durham, United States
2 AstraZeneca, Gaithersburg, United States
3 AstraZeneca, Gothenburg, Sweden
4 AstraZeneca, Cambridge, United Kingdom

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing